Cargando…
Outcomes Following Standardized Implantable Cardioverter-defibrillator Reprogramming
Multiple randomized controlled trials have demonstrated that programming implantable cardioverter-defibrillators (ICDs) with longer detection intervals and higher detection rates results in significant reductions in the delivery of inappropriate therapy without increasing the number of adverse event...
Autores principales: | Martini, Matthew, Kalscheur, Matthew, Dehn, Erin, McSherry, Teri, Leal, Miguel, Broman, Aimee, Kipp, Ryan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MediaSphere Medical
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023023/ https://www.ncbi.nlm.nih.gov/pubmed/35474860 http://dx.doi.org/10.19102/icrm.2022.130403 |
Ejemplares similares
-
Implantable cardioverter-defibrillators /
Publicado: (1994) -
Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021) -
Standard and extended electrocardiographic screening for the subcutaneous implantable cardioverter-defibrillator
por: Lewandowski, M, et al.
Publicado: (2023) -
Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022) -
The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)